This study was designed to determine whether analysis of the tumor markers CYFRA 21–1, CEA, and SCC in cytological fluid could improve the performance of NAB in the diagnosis of NSCLC. The gene discussed is CEACAM5; the disease is non-small cell lung carcinoma.